ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1852

Intestinal Permeability in the Adjuvant Induced Arthritis Model: Preliminary Study and Impact of NSAIDs

Sophie Hecquet1, Romain Bordy2, Clement Prati1, Daniel Wendling3, Céline Demougeot2 and Frank Verhoeven1, 1Rheumatology, University Teaching Hospital, Besançon, France, 2EA4267 Laboratory, Besançon, France, 3CHU Besançon, department of rheumatology, Besancon, France

Meeting: ACR Convergence 2020

Keywords: Animal Model, Nonsteroidal antiinflammatory drugs (NSAIDs), spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2020

Title: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: The gut is no longer considered as a simple element associated with spondyloarthritis but as a real actor of the disease. In patients with spondyloarthritis, the presence of intestinal inflammation and an increase in digestive permeability responsible for bacterial translocation has been described. No data are available on the effect of non-steroidal anti-inflammatory drugs (NSAIDs) on this bacterial translocation in patients with spondyloarthritis. Zonulin and lipopolysaccharide (LPS) have been described as good biomarkers of intestinal permeability and bacterial translocation, respectively. Adjuvant-induced arthritis (AIA) is a model of recent arthritis characterized by ossification and ankylosis in the post arthritis period. This model can be considered as a model of reactive arthritis in which our previous work has reported a clear efficacy of NSAIDs with differences between molecules at the structural and vascular levels.To test the hypothesis that there is an increase in digestive permeability and bacterial translocation in the AIA model and to show the influence of different NSAIDs on these two parameters.

Methods: Adjuvant-induced arthritis (AIA) was induced in 6-week-old male Lewis rats by an injection at the base of the tail of Mycobacterium butyricum in incomplete Freund’s adjuvant. A group of non-AIA (control) rats received saline. At the first signs of arthritis, the AIA-rats were evaluated (arthritis score 0-6) and treated daily intraperitoneally with naproxen (10 mg/kg/day), diclofenac (5mg/kg twice daily), celecoxib (3 mg/kg/day) or saline solution (AIA-vehicle group). After 21 days of treatment, the rats were sacrificed and serum levels of zonulin and LPS were evaluated by ELISA and liquid chromatography-mass spectrometry, respectively. Circulating levels of TNF-α and IL1-β were measured as well as the hind paw radiographic score.

Results: Compared to the control group, there was a significant increase in zonulin concentration ( p < 0.001) in the AIA group. There was no significant difference in the concentration of LPS between the two groups. The levels of zonulin were correlated with the TNF-α levels (R= -0.42; p=0.032) and the arthritis score (R=0.45; p=0.013) but not with the level of IL1-β (R=; p-0.018; p=0.39). Treatment with NSAIDs significantly and equivalently decreased the arthritis score in each group. Compared to the vehicle group, treatment with naproxen significantly decreased the radiographic score (p< 0.001), TNF-α, IL1-β (p < 0.01), zonulin (p< 0.001) and LPS (p < 0.05). Celecoxib decreased radiographic score (p < 0.001), IL1-β (p < 0.01), TNF-α (p < 0.01) but increased zonulin levels (p < 0.05) without effect on LPS. Diclofenac also decreased radiographic score (p < 0.001), TNF-α (p < 0.01), and IL1-β (p < 0.01) but increased both zonulin (p < 0.01) and LPS (p < 0.001).

Conclusion: We have demonstrated an increase in serum zonulin levels in the AIA model and a beneficial effect of naproxen on intestinal permeability and bacterial translocation in contrast to celecoxib and diclofenac. Moreover, the plasmatic zonulin levels were correlated with TNF-α but not with IL1-β supporting a pivotal role of TNF-α on the tight junctions in this model.


Disclosure: S. Hecquet, None; R. Bordy, None; C. Prati, None; D. Wendling, None; C. Demougeot, None; F. Verhoeven, None.

To cite this abstract in AMA style:

Hecquet S, Bordy R, Prati C, Wendling D, Demougeot C, Verhoeven F. Intestinal Permeability in the Adjuvant Induced Arthritis Model: Preliminary Study and Impact of NSAIDs [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/intestinal-permeability-in-the-adjuvant-induced-arthritis-model-preliminary-study-and-impact-of-nsaids/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/intestinal-permeability-in-the-adjuvant-induced-arthritis-model-preliminary-study-and-impact-of-nsaids/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology